Skip to content

Clinical trials

Completed Phase 2 Urologic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Phase: Phase 2 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20122
20143
20153
20181
20191
20211
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allena Pharmaceuticals3
Astellas Pharma Europe B.V.2
AbbVie1
Ain Shams University1
Alnylam Pharmaceuticals1
HI-Bio, A Biogen Company1
Kyowa Kirin Co., Ltd.1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases15
Kidney Diseases10
Hyperoxaluria4
Kidney Calculi3
Nephrolithiasis3
Urinary Bladder Diseases3
Diabetes Complications2
Diabetes Mellitus2
Diabetic Nephropathies2
Endocrine System Diseases2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.